IsoPlexis to Participate in Three Upcoming Investor Conferences
February 11 2022 - 7:00AM
IsoPlexis Corporation (Nasdaq: ISO), the Superhuman Cell Company,
today announced the company will be participating in the following
investor conferences.
- 11th Annual SVB Leerink Global Healthcare Conference,
VirtualFireside Chat on Wednesday, February 16th at 7:00 a.m.
Pacific Time / 10:00 a.m. Eastern Time
- Cowen 42nd Annual Health Care Conference, Virtual Fireside Chat
on Wednesday, March 9th at 6:10 a.m. Pacific Time / 9:10 a.m.
Eastern Time
- Barclays Global Healthcare ConferenceFireside Chat on Tuesday,
March 15th at 8:15 a.m. Pacific Time / 11:15 a.m. Eastern Time
Interested parties may access live and archived
webcasts on the “Investors” section of the company website at:
www.isoplexis.com.
About IsoPlexis
IsoPlexis is the Superhuman Cell company.
IsoPlexis’ systems uniquely identify a
comprehensive range of multifunctional single cells, i.e. the
superhero cells in the human body. These cells enable researchers
to understand and predict disease progression, treatment resistance
and therapeutic efficacy to advance all of human health.
IsoPlexis has been named Top Innovation or Design
by The Scientist Magazine, Fierce, BIG Innovation, Red Dot and
multiple others. The IsoPlexis platform is used globally by
researchers, including those at the top 15 global pharmaceutical
companies and at two-thirds of leading U.S. comprehensive cancer
centers.
Investor
Contactinvestors@isoplexis.com
Press
Contactpress@isoplexis.com
IsoPlexis (NASDAQ:ISO)
Historical Stock Chart
From Jun 2024 to Jul 2024
IsoPlexis (NASDAQ:ISO)
Historical Stock Chart
From Jul 2023 to Jul 2024